NCT01988155

Eccentric Exercise Versus Eccentric Exercise and Astym for Insertional Achilles Tendinopathy

Eccentric Exercise Versus Eccentric Exercise and Astym® in the Management of Insertional Achilles Tendinopathy: A Randomized Controlled Trial
Indiana University Health Ball Memorial Hospital Rehabiliation Services·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov
Study focus
Drug/Device/Intervention
Eccentric Exercise
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Indiana University Health Ball Memorial Hospital Rehabiliation Services
Location
Muncie, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2013
End date
Dec 01, 2015
Enrollment
16 participants
Primary outcome

Victorian Institute of Sport Assessment- Achilles Specific Questionnaire (VISA-A)

Summary

The purpose of this research study is to determine if Astym® treatment is an effective
 treatment for patients with Achilles pain. The usual treatment for this condition is a
 specific exercise program that has been previously shown to be effective. The research team
 is trying to determine if combining Astym with the exercise program is more effective than
 exercise program only.
 
 The main hypothesis for this study is that Astym plus eccentric exercise will be more
 effective than eccentric exercise alone at improving pain and function in patients with
 insertional Achilles tendinopathy.

ICD-10 classifications
Achilles tendinitisInjury of Achilles tendonShort Achilles tendon (acquired)Spontaneous rupture of unspecified tendonInjury of unspecified muscle and tendon at ankle and foot level
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT01988155
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT01988155 through Pure Global AI's free database. This phase not specified trial is sponsored by Indiana University Health Ball Memorial Hospital Rehabiliation Services and is currently Completed. The study focuses on Insertional Achilles Tendinopathy. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.